BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 34484166)

  • 1. Emergence of a KPC Variant Conferring Resistance to Ceftazidime-Avibactam in a Widespread ST11 Carbapenem-Resistant
    Li X; Quan J; Ke H; Wu W; Feng Y; Yu Y; Jiang Y
    Front Microbiol; 2021; 12():724272. PubMed ID: 34484166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Mechanisms Driving the
    Li X; Ke H; Wu W; Tu Y; Zhou H; Yu Y
    mSphere; 2021 Dec; 6(6):e0085921. PubMed ID: 34935448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftazidime-Avibactam Resistance in
    Li D; Li K; Dong H; Ren D; Gong D; Jiang F; Shi C; Li J; Zhang Q; Yan W; Li Y
    Infect Drug Resist; 2021; 14():1725-1731. PubMed ID: 34007191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristic of KPC-12, a KPC Variant Conferring Resistance to Ceftazidime-Avibactam in the Carbapenem-Resistant
    Han W; Zhou P; Chen C; Wu C; Shen L; Wan C; Xiao Y; Zhang J; Wang B; Shi J; Yuan X; Gao H; Wang H; Zhou Y; Yu F
    Infect Drug Resist; 2024; 17():2541-2554. PubMed ID: 38933778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic evolution of ceftazidime-avibactam resistance due to interchanges between
    Chen Y; Yang R; Guo P; Liu P; Deng J; Wu Z; Wu Q; Huang J; Liao K
    Front Cell Infect Microbiol; 2023; 13():1244511. PubMed ID: 37671146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KPC-2 allelic variants in
    Sanz MB; Pasteran F; de Mendieta JM; Brunetti F; Albornoz E; Rapoport M; Lucero C; Errecalde L; Nuñez MR; Monge R; Pennini M; Power P; Corso A; Gomez SA
    Microbiol Spectr; 2024 Mar; 12(3):e0411123. PubMed ID: 38319084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering variable resistance to novel carbapenem-based β-lactamase inhibitor combinations in a multi-clonal outbreak caused by Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam.
    Di Pilato V; Principe L; Andriani L; Aiezza N; Coppi M; Ricci S; Giani T; Luzzaro F; Rossolini GM
    Clin Microbiol Infect; 2023 Apr; 29(4):537.e1-537.e8. PubMed ID: 36414199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of a KPC-90 Variant that Confers Resistance to Ceftazidime-Avibactam in an ST463 Carbapenem-Resistant Pseudomonas aeruginosa Strain.
    Tu Y; Wang D; Zhu Y; Li J; Jiang Y; Wu W; Li X; Zhou H
    Microbiol Spectr; 2022 Feb; 10(1):e0186921. PubMed ID: 35019766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a KPC Variant Conferring Resistance to Ceftazidime-Avibactam from ST11 Carbapenem-Resistant
    Wu Y; Yang X; Liu C; Zhang Y; Cheung YC; Wai Chi Chan E; Chen S; Zhang R
    Microbiol Spectr; 2022 Apr; 10(2):e0265521. PubMed ID: 35416703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First Description of Ceftazidime/Avibactam Resistance in a ST13 KPC-70-Producing
    Mendes G; Ramalho JF; Bruschy-Fonseca A; Lito L; Duarte A; Melo-Cristino J; Caneiras C
    Antibiotics (Basel); 2022 Jan; 11(2):. PubMed ID: 35203770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel KPC-113 variant conferring carbapenem and ceftazidime-avibactam resistance in a multidrug-resistant Pseudomonas aeruginosa isolate.
    Yang Q; Li Y; Fang L; Lei T; Cai H; Hua X; Zheng M; Yu Y
    Clin Microbiol Infect; 2023 Mar; 29(3):387.e7-387.e14. PubMed ID: 36252790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of Ceftazidime/Avibactam and Tigecycline Resistance in Carbapenem-Resistant
    Han X; Shi Q; Mao Y; Quan J; Zhang P; Lan P; Jiang Y; Zhao D; Wu X; Hua X; Yu Y
    Front Cell Infect Microbiol; 2021; 11():757470. PubMed ID: 34760723
    [No Abstract]   [Full Text] [Related]  

  • 13. Emergence of KPC-113 and KPC-114 variants in ceftazidime-avibactam-resistant
    Vásquez-Ponce F; Bispo J; Becerra J; Fontana H; Pariona JGM; Esposito F; Fuga B; Oliveira FA; Brunetti F; Power P; Gutkind G; Schreiber AZ; Lincopan N
    Microbiol Spectr; 2023 Sep; 11(5):e0037423. PubMed ID: 37671877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of KPC-112 from an ST15 Klebsiella pneumoniae Strain Conferring Resistance to Ceftazidime-Avibactam.
    Shen S; Tang C; Ding L; Han R; Yin D; Yang W; Guo Y; Hu F
    mSphere; 2022 Dec; 7(6):e0048722. PubMed ID: 36374086
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Wang C; Zhao J; Liu Z; Sun A; Sun L; Li B; Lu B; Liu Y; Cao B
    Front Microbiol; 2021; 12():727946. PubMed ID: 34630354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and Molecular Epidemiologic Characteristics of Ceftazidime/Avibactam-Resistant Carbapenem-Resistant
    Zhou J; Yang J; Hu F; Gao K; Sun J; Yang J
    Infect Drug Resist; 2020; 13():2571-2578. PubMed ID: 32801794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Klebsiella pneumoniae carbapenemase (KPC) producer resistant to ceftazidime-avibactam due to a deletion in the blaKPC3 gene.
    Antinori E; Unali I; Bertoncelli A; Mazzariol A
    Clin Microbiol Infect; 2020 Jul; 26(7):946.e1-946.e3. PubMed ID: 32061796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceftazidime-avibactam resistance and restoration of carbapenem susceptibility in KPC-producing Klebsiella pneumoniae infections: A case series.
    van Asten SAV; Boattini M; Kraakman MEM; Bianco G; Iannaccone M; Costa C; Cavallo R; Bernards AT
    J Infect Chemother; 2021 May; 27(5):778-780. PubMed ID: 33558042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China.
    Zhang P; Shi Q; Hu H; Hong B; Wu X; Du X; Akova M; Yu Y
    Clin Microbiol Infect; 2020 Jan; 26(1):124.e1-124.e4. PubMed ID: 31494252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of In Vitro Efficacy of Ceftazidime-Avibactam, Meropenem, and Colistin Single and Binary Combinations Against Carbapenem Resistant Klebsiella pneumoniae Strains Isolated from Various Clinical Specimens].
    Köle M; Sesli Çetin E; Şirin MC; Cicioğlu Arıdoğan B
    Mikrobiyol Bul; 2022 Apr; 56(2):230-250. PubMed ID: 35477227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.